Terapia con células madre: A Hope for Stage 5 Enfermedad renal crónica
Enfermedad renal crónica (ERC) Es una condición debilitante que afecta a millones de personas en todo el mundo.. In its advanced stage, known as Stage 5 ERC, the kidneys lose their ability to function effectively, leading to a buildup of waste products in the blood and potentially life-threatening complications. Conventional treatments for Stage 5 CKD include dialysis and kidney transplantation, which can be expensive, invasive, and have limited availability. Terapia con células madre ofrece una alternativa prometedora, providing hope for patients with this devastating disease.
Understanding Stage 5 Enfermedad renal crónica
Escenario 5 CKD occurs when the kidneys have lost 85% or more of their function. The kidneys play a crucial role in filtering waste products from the blood, regulating blood pressure, and producing essential hormones. In Stage 5 ERC, these functions are severely impaired, leading to a buildup of toxins, fluid retention, and electrolyte imbalances. Patients with Stage 5 CKD require dialysis or kidney transplantation to survive.
El papel de las células madre en la regeneración renal
Las células madre son células indiferenciadas que tienen el potencial de convertirse en varios tipos de células especializadas.. En el contexto de la ERC, stem cells offer the possibility of regenerating damaged kidney tissue and restoring kidney function. Terapia con células madre involves harvesting stem cells from the patient’s own body or from a donor, then transplanting them into the kidneys. Una vez trasplantado, the stem cells have the potential to differentiate into new kidney cells, repairing damaged tissue and improving kidney function.
